New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2022, WHO guidelines for malaria, 3 June 2022.
View latest version (2022)Bibliographic Info
GuidelineWHO guidelines for malaria, 18 February 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Retired
Recommended in favor
Strong
In areas of moderate-to-high malaria transmission of Africa, where sulfadoxine-pyrimethamine (SP) is still effective, provide intermittent preventive treatment with SP to infants (< 12 months of age) (SP-IPTi) at the time of the second and third rounds of vaccination against diphtheria, tetanus and pertussis (DTP) and vaccination against measles.